Announced Wed, 7 Oct, 2026 · 13:05 IST
Compliance certificate for share dematerialisation for Q2 FY26
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.9%1-day move
₹101.46
prior close
₹96.39
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+3.6-5.9—————————
Up moveDown movePending
AI summary
Bal Pharma filed a routine compliance certificate with BSE and NSE for the quarter ended 30 September 2026. The certificate, issued by its Registrar MUFG Intime India, confirms that all share dematerialisation requests received during the quarter were processed and records updated within SEBI's prescribed 15-day timeline. No material business or financial details are disclosed in this filing.
Likely market impact
Routine regulatory compliance filing. No material impact on shareholders or stock price.